United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$56Mraised across 2 rounds since 2003, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Gimv
Kester CapitalFrom a historical funding record
GimvFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Xanthus Pharmaceuticals's investors include Gimv, HealthCare Ventures, Hambrecht & Quist Capital Management, GeneChem and CDP Capital Technology Ventures, and 8 more on record.
Xanthus Pharmaceuticals has raised $56M across 2 rounds since 2003.
Xanthus Pharmaceuticals's most recent round was a Series B of $25M in Dec 2006.
Xanthus Pharmaceuticals's largest round on record is $31M (Series B), in Dec 2003.
Xanthus Pharmaceuticals's first round on record, in Dec 2003, was backed by Gimv, Oxford Bioscience Partners and HealthCare Ventures and 8 others.
Xanthus Pharmaceuticals's latest named round is a Series B, in Dec 2006.
Xanthus Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
